Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
PaperCitations, authors & open-access status
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 556 citations, 2020 year and hybrid oa status.
556
Citations
2020
Year
hybrid
OA Status